Literature DB >> 11226957

Altered MUC1 and MUC2 glycoprotein expression in laryngeal cancer.

J P Jeannon1, F W Stafford, J V Soames, J A Wilson.   

Abstract

The purpose of this study was to determine whether mucin expression is altered in laryngeal cancer. MUC1 and MUC2 mucin expression was examined in biopsy specimens from 80 patients that comprised 23 laryngeal dysplasias, 36 laryngeal carcinomas, and 21 normal larynx control specimens. High MUC1 expression was found in all 3 groups (P = 0.689, Fisher exact test). However, significantly higher levels of MUC2 expression were detected in carcinomas compared with dysplasias and control specimens (P = 0.009, Fisher exact test). Altered MUC2 expression may be an important step in carcinogenesis in laryngeal cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226957     DOI: 10.1067/mhn.2001.112481

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  6 in total

1.  MUC1 mucin and carbohydrate associated antigens as tumor markers in head and neck squamous cell carcinoma.

Authors:  M V Croce; M E Rabassa; M R Price; A Segal-Eiras
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

2.  Influence of sialic acid removal on MUC1 antigenic reactivity in head and neck carcinoma.

Authors:  María V Croce; Martín E Rabassa; Adrián Pereyra; Amada Segal-Eiras
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

3.  Distribution of mucins and antimicrobial substances lysozyme and lactoferrin in the laryngeal subglottic region.

Authors:  Hannes Kutta; Andreas Willer; Philipp Steven; Lars Bräuer; Michael Tsokos; Friedrich Paulsen
Journal:  J Anat       Date:  2008-07-22       Impact factor: 2.610

4.  Potential ferroptosis-related diagnostic and prognostic biomarkers in laryngeal cancer.

Authors:  Zao Ji; Zhiyao Fang; Xue Dong; Jia Wang; Xianyao Wan; Aihui Yan
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-07-12       Impact factor: 3.236

Review 5.  MUC1: The First Respiratory Mucin with an Anti-Inflammatory Function.

Authors:  Kosuke Kato; Erik P Lillehoj; Wenju Lu; Kwang Chul Kim
Journal:  J Clin Med       Date:  2017-11-29       Impact factor: 4.241

6.  MUC1 confers radioresistance in head and neck squamous cell carcinoma (HNSCC) cells.

Authors:  Tian-Qiao Huang; Ya-Nan Bi; Zheng Cui; Jin-Ping Guan; Yi-Chuan Huang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.